Samieirad S, Sharifian-Attar A, Eshghpour M, Mianbandi V, Shadkam E, Hosseini-Abrishami M, Hashemipour M-S
Department of Oral Medicine, School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran,
Med Oral Patol Oral Cir Bucal. 2018 Nov 1;23(6):e767-e776. doi: 10.4317/medoral.22493.
The aim of this randomized controlled triple blind trial was to compare the efficacy of clonidine with dexamethasone versus ondansetron with dexamethasone for postoperative pain, nausea and vomiting prevention in orthognathic surgery patients.
In this clinical trial study, 30 consecutive patients with skeletal class III deformities were candidates for orthognathic surgery in Qaem hospital, Mashhad University of medical sciences, Mashhad, Iran from March to November 2017. These subjects were randomly assigned to two equal number groups, ondansetron or clonidine. Patients received either oral ondansetron 8mg or oral clonidine 150μg as premedication, 1 hour before the surgery (both dissolved in 20 cc of water). Also both groups received intravenous dexamethasone 8mg (1 hour preoperatively and every 4 hours intraoperatively).
In this study, a total of 30 patients (14 males and 16 females) with a mean age of 23.9 ± 3.9 were investigated. The incidence of postoperative nausea in women was more than men (p=0.003), also the correlation between the incidence of PON and the surgery duration ≥ 3 hours was statistically significant (p = 0.050). The frequency of postoperative nausea (PON) in the ondansetron group was less than clonidine (53.3% vs 73.3% respectively). There was no postoperative vomiting (POV) in the ondansetron group, but 6.7% of cases in clonidine group suffered POV. Post-operative nausea in ondansetron group occurred significantly later than clonidine (525.0±233.2 vs 100.0±34.0 min; p <0.001). On the other hand, the incidence time of post-operative severe pain or in other word the analgesia time in clonidine group was significantly more than ondansetron one (875/0±68/5 vs 614.3±159.1 min; p <0.001).
Ondansetron with dexamethasone premedication was more effective in controlling PONV after orthognathic surgery compared to clonidine with dexamethasone group.
这项随机对照三盲试验的目的是比较可乐定联合地塞米松与昂丹司琼联合地塞米松在正颌手术患者术后疼痛、恶心和呕吐预防方面的疗效。
在这项临床试验研究中,2017年3月至11月期间,伊朗马什哈德医科大学Qaem医院30例连续的骨骼Ⅲ类畸形患者成为正颌手术的候选者。这些受试者被随机分为两组,每组人数相等,分别为昂丹司琼组或可乐定组。患者在手术前1小时接受口服8mg昂丹司琼或口服150μg可乐定作为术前用药(均溶于20cc水中)。两组患者还均接受静脉注射8mg地塞米松(术前1小时及术中每4小时一次)。
本研究共调查了30例患者(14例男性和16例女性),平均年龄为23.9±3.9岁。女性术后恶心的发生率高于男性(p=0.003),术后恶心发生率与手术时间≥3小时之间的相关性也具有统计学意义(p = 0.050)。昂丹司琼组术后恶心(PON)的发生率低于可乐定组(分别为53.3%和73.3%)。昂丹司琼组无术后呕吐(POV),但可乐定组有6.7%的病例发生POV。昂丹司琼组术后恶心发生时间明显晚于可乐定组(525.0±233.2 vs 100.0±34.0分钟;p <0.001)。另一方面,可乐定组术后严重疼痛的发生时间或镇痛时间明显长于昂丹司琼组(875.0±68.5 vs 614.3±159.1分钟;p <0.001)。
与可乐定联合地塞米松组相比,昂丹司琼联合地塞米松术前用药在控制正颌手术后的PONV方面更有效。